Cancer
Any cancer post other than mbc
About Her—HER2, that is
On April 17, the FDA approved a new drug called Tukysa (tucatinib) for use in combination with chemotherapy for patients with HER2-positive breast cancer that has metastasized to the brain. All new treatment options are good news, but this is particularly good news because: HER2-positive breast cancer is not as common as HER2-negative, thankfully, because …
The effects of side effects
Joint and muscle pain. Hair loss. Vision anomalies. Dry skin. These are some of the unwanted symptoms that I and many others experience as side effects of treatment for metastatic breast cancer, or MBC as I prefer to call it. Side effects are the unintended consequences of drug treatments. Usually they’re unwanted, but sometimes they’re …